Clinical Trial Update: Lyrica (Pregabalin) Korean Post Marketing Surveillance Study

View source ↗

Summary

A completed post-marketing surveillance study of pregabalin (Lyrica) in Korea, with results posted in 2011, focusing on epilepsy and neuropathic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Neuropathic Pain

Drugs mentioned

• Lyrica (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Epilepsy, Neuropathic Pain | Status: COMPLETED | Results posted: 2011-12-08